Quarterly report [Sections 13 or 15(d)]

REVENUES - Disaggregated (Details)

v3.25.1
REVENUES - Disaggregated (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Disaggregation of Revenue [Line Items]    
Total revenues $ 53,333 $ 29,534
Gross product sales    
Disaggregation of Revenue [Line Items]    
Total revenues 60,192 38,426
Discounts and allowances    
Disaggregation of Revenue [Line Items]    
Total revenues (16,642) (12,423)
Product sales, net    
Disaggregation of Revenue [Line Items]    
Total revenues 43,550 26,003
Milestone    
Disaggregation of Revenue [Line Items]    
Total revenues 3,000  
Delivery of drug supplies, royalty and others    
Disaggregation of Revenue [Line Items]    
Total revenues 6,783 3,531
Contract revenues from collaborations    
Disaggregation of Revenue [Line Items]    
Total revenues $ 9,783 $ 3,531